Joel Edward Lavine, MD, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who’s Who
Dr. Joel Edward Lavine’s work has been cited over 27,000 times.
NEW YORK, NY, August 28, 2020 /24-7PressRelease/ — Marquis Who’s Who, the world’s premier publisher of biographical profiles, is proud to present Joel Edward Lavine, MD, PhD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Lavine celebrates many years’ experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
A renowned medical professional and educator of over 30 years, Dr. Lavine remains tenured with Columbia University in New York as a Professor of Pediatrics since 2010. He was former Vice-Chair of Research in the Department from 2014 to 2019, served as Chief of the Division of Gastroenterology, Hepatology and Nutrition between 2010 and 2020. Dr. Lavine also served as an Attending physician and the Director of the Division of Gastroenterology. Hepatology and Nutrition at New York-Presbyterian. Morgan Stanley Children’s Hospital in New York since 2010 until recently. During his tenure at New York-Presbyterian, he notably developed the Phyllis and Ivan Seidenberg Children’s Digestive Health Center for outpatient digestive disease care.
Dr. Lavine’s career in academia began in 1989 as an Assistant Professor of Pediatrics at the University of California (UC), San Francisco. He later taught and directed Liver Research at Harvard Medical School from 1991 to 1995 before returning to UC San Diego as a full Professor, Vice Chair of Pediatrics for Fellow and Faculty Developmcnt and Chief of the Division of Gastroenterology, Hepatology and Nutrition from 1995 to 20 IO. He also served as Chief of the Division at Rady Children’s Hospital in San Diego. While in San Diego, Dr. Lavine was responsible for establishing the sale liver transplant program for children in the county and Arizona. He also initiated the first Pediatric GI Fellowship program at UCSD hired over 20 new faculty, and established the first dedicated programs in the United States for Fatty Liver Diseases and for Eosinophilic Esophagitis.
As a consultant his field, Dr. Lavine has worked with over 30 organizations, including Novartis, Merck, Pfizer, Allergan, NovoNordisk, Takeda, Intercept, Bristol Myers Squibb and Gilead. He has been an External Advisor to the FDA, the NIH, and Department of Defense. He has also served as a mentor and advisor on multiple occasions to junior faculty, pre-and post-doctoral trainees, and resident physicians. Furthermore, Dr. Lavine was a Visiting Professor at the American College of Veterinary Medicine, the National Institutes of Health and Emory University, has presented nationally and internationally as a lecturer, symposium speaker and moderator, has been a keynote speaker, and has had the pleasure of serving as the graduation speaker at the UC San Diego School of Medicine.
Dr. Lavine’s extensive research, which has been funded by numerous grants over the years, has focused on basic, translational and clinical sciences, in disciplines that have included pediatrics, internal medicine, pathology, infectious disease, and radiology. He has specifically addressed clinical problems due to obesity in children and adults. He has also spent much of his career studying nonalcoholic fatty liver disease (NAFLD), a chronic liver disease in American adults and children that affects approximately 25% of American adults, and non-alcoholic steatohepatitis (NASH), a more serious type of NAFLD. As a result, Dr. Lavine was responsible for discovering the only currently recommended treatment for NASH in Guidelines published by the American Association for the Study of Liver Diseases and the American Gastroenterological Association. Additionally, he discovered the genetic basis for multiple GI/liver disorder. He served on the Executive Committee and as the Co-chair of the Steering Committee of the NIH-funded NASH Clinical Research Network for 18 years.
Dr. Lavine is a prolific author. He was also a guest editor and author of “Seminars in Liver Disease” in 1994, with a second edition he edited in 2012. He has written chapters for numerous books, served on the Editorial Board of Hepatology, a peer reviewed journal beginning in 1994, and has disseminated research findings in more than 175 peer-reviewed publications. His work has been cited over 27,000 times. Dr. Lavine has also contributed a significant number of reviews, monographs, editorials, abstracts and poster presentations to the field.
An alumnus of UC Dr. Lavine received a Bachelor of Arts in biochemistry on the Berkeley campus in 1975. He later attained a Doctor of Philosophy in Biological Sciences at UC Santa Barbara in 1980 and a Doctor of Medicine in San Diego in 1984. Additional educational pursuits to his credit include an internship and residency in Pediatrics, followed by a fellowship in Pediatric Gastroenterology, Hepatology and Nutrition at UC, San Francisco. Board-certified by the American Board of Pediatrics, Dr. Lavine is also certified in Pediatrics, Pediatric Gastroenterology and Hepatology, and received a certificate of added qualification in transplant hepatology. Licensed to practice medicine in New York. He was formerly licensed in both Massachusetts and California.
As a commitment to his field, Dr. Lavine has played an active role as a member of several professional society organizations, including the American Association for the Study of Liver Diseases, the North American Society for Pediatric Gastroenterology, and the American Pediatric Society where he has served in various capacities. He has also been a fellow of the American Academy of Pediatrics and the American Gastroenterological Association and the founder/organizer of the parent and child suppol1 group of the American Liver Foundation’s San Diego chapter. Well regarded in his field, Dr. Lavine was the recipient of a Pediatric Research Prize from the American Liver Foundation in 1989, and was later bestowed with a Research Scholar Award from the American Gastroenterological Association from 1991 until 1994. The award is notably presented to early-career faculty who focus their careers on digestive disease research. Named to Best Doctors, Top Doctors and Super Doctors several times over in San Diego and New York, he has also been cited in several editions of Who’s Who in America, Who’s Who in the East and Who’s Who in the West.
About Marquis Who’s Who®
Since 1899, when A. N. Marquis printed the First Edition of Who’s Who in America®, Marquis Who’s Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who’s Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who’s Who titles, including Who’s Who in America®, Who’s Who in the World®, Who’s Who in American Law®, Who’s Who in Medicine and Healthcare®, Who’s Who in Science and Engineering®, and Who’s Who in Asia®. Marquis® publications may be visited at the official Marquis Who’s Who® website at www.marquiswhoswho.com.
# # #
Originally Published on : https://www.24-7pressrelease.com/press-release/475287/joel-edward-lavine-md-phd-presented-with-the-albert-nelson-marquis-lifetime-achievement-award-by-marquis-whos-who
Contact/WhatsAPP: +91 7827887720 EMAIL: [email protected]
Disclaimer: The perspectives communicated in the article/news/press release above are those of the writers’ and don’t really speak to or mirror the perspectives of this website or its personnel. Except if in any case noticed, the writer is writing in his/her own ability. They are not expected and ought not to be thought to speak to legitimate thoughts, perspectives, or strategies of any individual, Institution, organization or foundation.